Amwill Health Care Ltd (AMWILL) — shareholding pattern, promoter holding, financials and share price
About Amwill Health Care Ltd (AMWILL)
Amwill Health Care Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as AMWILL and on the BSE under scrip code 544353. Its ISIN is INE0U2L01017.
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products [1]
Amwill Health Care Ltd is a derma-cosmetic company specializing in dermatological, cosmeceutical, and aesthetic products. It focuses on product formulation and development, outsourcing manufacturing and distribution to third-party agencies to streamline operations.
The company plans to raise capital through an Initial Public Offering, offering 62,00,000 equity shares, which includes a fresh issue of 50,00,000 shares and an offer for sale of 12,00,000 shares.
Listed peers in Pharmaceuticals: Makers Laboratories Ltd, Curis Lifesciences Ltd, Samrat Pharmachem Ltd, Zenith Drugs Ltd, Veerhealth Care Ltd, Bharat Immunological & Biological Corporation Ltd.
Valuation & Returns
10 Jul 2026At ₹41 a share on 10 Jul 2026, Amwill Health Care Ltd (AMWILL) was valued at a price-to-earnings ratio of 7.15x against an industry P/E of 36.41x and a price-to-book of 1.01x on a book value of ₹40.28 per share. Solomo computes return on equity of 14.17% and return on capital employed of 19.07% from filed results.
- P/E
- 7.15x
- Industry P/E
- 36.41x
- P/B
- 1.01x
- EPS (TTM)
- ₹6.63
- Book value / share
- ₹40.28
- ROE
- 14.17%
- ROCE
- 19.07%
- ROA
- 13.18%
- Debt / equity
- 0x
- Dividend yield
- 1.22%
- EBITDA margin
- 34.97%
- 52-week range
- ₹28.91 – ₹71
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Amwill Health Care Ltd (AMWILL) reported revenue of ₹45 crore, net profit of ₹11 crore and earnings per share of ₹5.71. That compares with revenue of ₹37 crore and net profit of ₹11 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹24 crore and net profit ₹8 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 26 | 28 | 42 | 37 | 45 |
| Net profit (₹ cr) | 3 | 3 | 12 | 11 | 11 |
| EPS (₹) | 856.67 | 1,036.67 | 2,500 | 5.36 | 5.71 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 13.69% | -7.67% |
| Profit growth | 60.95% | -14.16% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 70.65% of Amwill Health Care Ltd (AMWILL). Market capitalisation was ₹82 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2025.
Largest disclosed public shareholders in Mar 2026: FEONA KETAN SHAH 2.95%, VARUN KRISHNAVTAR KABRA 2.44%, ABHISHEK JAIN 2.34%, GLOBALWORTH SECURITIES LIMITED 1.45%, KETAN KESHAVJI SHAH 1%, HARSHAD RASIKLAL SHETH 1%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 70.65% | - | - | - | 29.35% |
| Sep 2025 | 70.65% | - | 1.16% | - | 29.35% |
| Mar 2025 | 70.65% | - | 1.16% | - | 29.35% |